IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Medical Tissue Closures procurement and pricing environment in the United States includes market dynamics, buyer power scores, supply chain vendors with pricing trends and forecasts.
This procurement coverage of the Medical Tissue Closures market in the United States includes Sutures, Staplers, Skin Closure Strips, Tissue Adhesives and Ligating Clips. Standard coding in this coverage includes HS-300610-Pharmaceutical Goods; Sterile Surgical Catgut, Suture Materials, Tissue Adhesives, Laminaria, Laminaria Tents, Absorbable Surgical Or Dental Haemostatics, And Surgical Or Dental Adhesion Barriers, ISIC-325-Manufacture of medical and dental instruments and supplies, NACE-32.50-Manufacture Of Medical And Dental Instruments And Supplies, NAICS-339110-Medical equipment and supplies manufacturing and UNSPSC-42312000-Medical tissue closure and related products.
Common market terminology included in the Medical Tissue Closures procurement coverage includes Group Purchasing Organization (GPO) (A group of businesses that form to leverage their purchasing power and gain discounts from vendors based on their collective buying power.), Quality Instrument Tracking Systems (The systems of tracking inventory at any point of the work cycle to help hospitals improve their inventory management and productivity.) and Obstetrics & Gynecology (Branches of medical science that focus on the medical care of women and female reproductive organs, including both pregnant and nonpregnant patients.).
The top companies covered in the Medical Tissue Closures procurement report as suppliers are Baxter International Inc., Henry Schein Inc., Cardinal Health, Inc., Mckesson Corporation and B. Braun Medical Inc..
The Opportunity Assessment chapter provides a comprehensive market analysis of the Medical Tissue Closures market in the United States category, including buyer power scoring, market pricing trends, vendor landscape, cost structure, and strategic negotiation levers.
The market pricing trends include the Market Price (2025) per surgical clip, a five year price forecast and a supply chain risk score. Vendor coverage includes a market share and cost structure breakdown.
Analysis includes a comprehensive SWOT analysis of and recent developments impacting the Medical Tissue Closures market environment.
The Buyer Power Score chapter assesses key components impacting Medical Tissue Closures procurement including the recent price trend, forecast price trend, availability of substitutes, switching costs, product specialization, average vendor risk, market share concentration, supply chain risk, price driver volatility and recent price volatility.
These components generate a Buyer Power Score that ranges from -5 (strongly favoring sellers) to +5 (strongly favoring buyers) plus a recommended strategy for procurement specialists.
The Price Environment chapter covers detailed pricing analysis and datasets on Medical Tissue Closures market environment. This includes insights into market pricing Market Price (2025), price forecasts, volatility, specialization, substitutes and switching costs.
Datasets in the Price Environment chapter include vendor cost structure, breakdowns of wage rates by geography and specialty, key external economic and labor drivers impacting the market and market pricing models.
The Supply Chain & Vendors chapter covers the concentration, risk and diversity of the Medical Tissue Closures market. This includes datasets on the market’s top suppliers, detailed analysis on the key sourcing risks and supply chain dynamics, with environmental, social and governance (ESG) considerations and scores.
The Business Requirements chapter covers vendor relationships, qualifications, service level agreements and key performance indicators. These inputs provide insight into the planning process through the buying lead time, vendor relationship and vendor qualifications. The sourcing process include key RFP elements like an organizational overview, project budget, selection criteria, project schedule, proposal format, inventory control, cost containment, regulation, quality control, distribution and key contract clauses.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
The 2026 benchmark market price for Medical Tissue Closures is $21.6 per surgical clip. Prices have declined at a CAGR of -3.18 from 2022-25.
The top vendors in the Medical Tissue Closures market include Baxter International Inc., Henry Schein Inc., Cardinal Health, Inc., Mckesson Corporation and B. Braun Medical Inc..
The top industries supplying the Medical Tissue Closures market are Industrial Machinery & Equipment Wholesaling in the US, Power Tools & Other General Purpose Machinery Manufacturing in the US, Plastics Wholesaling in the US, Petroleum Refining in the US, Iron & Steel Manufacturing in the US and Iron Ore Mining in the US.
High supply chain risk limits reliability and heightens exposure to international disruptions. With a high supply chain risk level, the medical tissue closures market remains vulnerable to international logistics delays, raw material fluctuations, and regulatory changes. Buyers face potential delivery uncertainty and longer lead times, requiring contingency planning and diversified sourcing strategies. Building safety stock, negotiating stronger service-level agreements, and monitoring upstream suppliers are critical to reducing exposure to disruption. Buyers who proactively strengthen supply chain visibility and establish dual sourcing arrangements will be better positioned to maintain consistent supply in volatile conditions.
Performance and speed in medical tissue closures are critical factors that directly affect pricing, as products that facilitate faster surgical procedures or enhance closure reliability tend to command higher prices due to their ability to improve patient outcomes and operational efficiency. Advanced surgical clips that offer quicker application and enhanced tissue integration may be priced higher than traditional staples, reflecting their value in reducing surgery time and associated costs in hospitals and clinics.